Table 2.
Distribution | Source | |||
---|---|---|---|---|
Intervention costs | ||||
SAVR | 25,474 | Multivariate normal4 | [4]* | |
TAVI | 33,178 | Multivariate normal4 | [4]* | |
Event treatment costs | ||||
Stroke | 3054 | Multivariate normal4 | [4]* | |
Myocardial infarction | 5157 | Multivariate normal4 | [4]* | |
Vascular complications | 5112 | Uniform (∓ 20%) | [48] | |
Reexploration for bleeding | 5048 | Uniform (∓ 20%) | [48] | |
Bleeding | 1617 | Uniform (∓ 20%) | [48] | |
Atrial fibrillation (without PI) | 1225 | Multivariate normal4 | [4]* | |
Pacemaker implantation (PI) | 11,738 | Multivariate normal4 | [4]* | |
Acute kidney injury/renal failure | 9650 | Multivariate normal4 | [4]* | |
Prosthetic valve dysfunction | 1478 | Uniform (∓ 20%) | [49–54] | |
Prosthetic valve thrombosis | 5824 | Uniform (∓ 20%) | [53–55] | |
Prosthetic valve endocarditis | 8923 | Multivariate normal4 | [4]* | |
Re-intervention SAVR | 25,936 | Multivariate normal4 | [4]* | |
Re-intervention TAVI | 33,178 | Multivariate normal4 | [4]* | |
Other healthcare cost1 | ||||
Post-intervention year 1 | 18,479 | Multivariate normal4 | [4]* | |
Post-intervention year 2 | 10,607 | [4]* | ||
Post-intervention year 3 | 10,832 | [4]* | ||
Productivity costs of unpaid work3 | Costs per month | |||
SAVR | 44 | Multivariate normal4 | [23] | |
TAVI | 50 | Multivariate normal4 | [23] | |
Informal care costs3 | Costs per month | |||
SAVR | 164 | Multivariate normal4 | [23] | |
TAVI | 388 | Multivariate normal4 | [23] | |
Utilities at start of the simulation | ||||
SAVR | 0.837 | Multivariate normal4 | [23] | |
TAVI | 0.718 | Multivariate normal4 | [23] | |
Utilities after events | Utility multiplier | Duration | ||
Stroke | 0.841 | Lifetime | Uniform5 | [56, 57] |
Myocardial infarction | 0.914 | 1 year | Uniform5 | [58, 59] |
Vascular complications | 0.981 | 1 week | Uniform5 | [60] |
Bleeding | 0.965 | 1 year | Uniform5 | [61] |
Atrial fibrillation (without PI) | 0.955 | 1 year | Uniform5 | [62] |
Pacemaker implantation (PI) | 0.804 | 1 month | Uniform5 | [63] |
Acute kidney injury/renal failure | 0.804 | 1 year | Uniform5 | [64] |
Re-intervention | 0.946 |
SAVR/TAVI: 4/1 month(s) |
Uniform5 | [65]/[8] |
Conservative treatment of: | ||||
Prosthetic valve dysfunction | 0.8862 | Lifetime | Uniform5 | [50, 66] |
Prosthetic valve thrombosis | 0.9682 | 10 days | Uniform5 | [55, 67] |
Prosthetic valve endocarditis | 0.9682 | 6 weeks | Uniform5 | [67, 68] |
*Mean in the Vektis database adjusted to 2016€. Costs in the model dependent on patient and intervention characteristics using (M)GLM [4]
1Mean total healthcare costs per year including costs of treatment of events and death (costs types are estimated separately in the model), but excluding intervention costs. Costs are based on data of SAVR patients, but it is assumed they are also applicable to TAVI patients
2Conservative treatment, no re-intervention
3Mean across all patients, including patients without unpaid work or informal care
4Multivariate normal distribution: coefficients of the regression model are randomly drawn from a multivariate normal distribution based on coefficients and variance–covariance matrix
550% deviation of 1-utility multiplier to prevent the utility multiplier from exceeding 1